Efficacy and tolerability of ABVD and Stanford V for elderly advanced-stage Hodgkin lymphoma (HL): Analysis from the phase III randomized US Intergroup Trial E2496 Evens, A. M., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N., Connors, J. M., Wagner, H., Gospodarowicz, M. K., Cheson, B. D., Advani, R., Kahl, B. S., Hoppe, R. T., Horning, S. J. AMER SOC CLINICAL ONCOLOGY. 2011

View details for DOI 10.1200/jco.2011.29.15_suppl.8035

View details for Web of Science ID 000208880302349